胺碘酮在急诊治疗快速型心律失常中的临床效果及安全性探究

Clinical Efficacy and Safety of Amiodarone in Emergency Treatment of Tachyarrhythmia

目的:探讨胺碘酮在急诊治疗快速型心律失常中的临床效果及安全性。方法:选取2015年1月-2019年12月笔者所在医院接受急诊治疗的120例快速型心律失常患者作为研究对象,使用随机数字法将其分为观察组(60例)与对照组(60例)。观察组采用胺碘酮治疗,对照组采用常规治疗。比较两组治疗效果。结果:观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05)。治疗后,两组血压、心率均低于治疗前,且观察组均低于对照组,差异有统计学意义(P<0.05)。观察组不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论:胺碘酮在急诊治疗快速型心律失常中的效果显著,且安全性较高,有临床推广应用价值。

Objective:To investigate the clinical efficacy and safety of Amiodarone in emergency treatment of tachyarrhythmia.Method:A total of 120 patients with tachyarrhythmia who received emergency treatment in our hospital from January 2015 to December 2019 were selected as the research subjects,and they were divided into the observation group(60 cases)and the control group(60 cases)by random number method.The observation group was treated with Amiodarone,and the control group was treated with conventional treatment.The therapeutic effect of the two groups was compared.Result:The total effective rate of the observation group was higher than that of the control group,and the difference was statistically significant(P<0.05).After treatment,blood pressure and heart rate in both groups were lower than those before treatment,and the observation group was lower than the control group,the differences were statistically significant(P<0.05).The incidence of adverse reactions in the observation group was lower than that in the control group,and the difference was statistically significant(P<0.05).Conclusion:Amiodarone has significant effect in emergency treatment of tachyarrhythmia,with high safety,and has clinical application value.